BioForce Nanosciences Holdings Inc
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www… Read more
BioForce Nanosciences Holdings Inc (BFNH) - Total Assets
Latest total assets as of September 2025: $784.00 USD
Based on the latest financial reports, BioForce Nanosciences Holdings Inc (BFNH) holds total assets worth $784.00 USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
BioForce Nanosciences Holdings Inc - Total Assets Trend (2002–2024)
This chart illustrates how BioForce Nanosciences Holdings Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
BioForce Nanosciences Holdings Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
BioForce Nanosciences Holdings Inc's total assets of $784.00 consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 100.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2002–2024)
This chart illustrates how BioForce Nanosciences Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BioForce Nanosciences Holdings Inc's current assets represent 100.0% of total assets in 2024, an increase from 66.4% in 2002.
- Cash Position: Cash and equivalents constituted 100.0% of total assets in 2024, up from 64.3% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 2.0% in 2002.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
BioForce Nanosciences Holdings Inc Competitors by Total Assets
Key competitors of BioForce Nanosciences Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
B&G Foods Inc
NYSE:BGS
|
USA | $2.94 Billion |
|
Tangrenshen Group Co Ltd
SHE:002567
|
China | CN¥17.90 Billion |
|
Shenzhen Shenbao Industrial Co Ltd
SHE:000019
|
China | CN¥7.01 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
BioForce Nanosciences Holdings Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - BioForce Nanosciences Holdings Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - BioForce Nanosciences Holdings Inc is currently not profitable relative to its asset base.
BioForce Nanosciences Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.00 | 0.00 | 0.10 |
| Quick Ratio | 0.00 | 0.00 | 0.10 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-499.94K | $ -2.18 Million | $ -359.91K |
BioForce Nanosciences Holdings Inc - Advanced Valuation Insights
This section examines the relationship between BioForce Nanosciences Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 866.24 |
| Latest Market Cap to Assets Ratio | 5596.78 |
| Asset Growth Rate (YoY) | 35.1% |
| Total Assets | $862.00 |
| Market Capitalization | $4.82 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values BioForce Nanosciences Holdings Inc's assets at a significant premium ( 5596.78x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: BioForce Nanosciences Holdings Inc's assets grew by 35.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for BioForce Nanosciences Holdings Inc (2002–2024)
The table below shows the annual total assets of BioForce Nanosciences Holdings Inc from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $862.00 | +35.11% |
| 2023-12-31 | $638.00 | -13.08% |
| 2022-12-31 | $734.00 | -93.41% |
| 2021-12-31 | $11.14K | -72.04% |
| 2020-12-31 | $39.87K | -32.31% |
| 2019-12-31 | $58.90K | +67.66% |
| 2018-12-31 | $35.13K | +68.01% |
| 2017-12-31 | $20.91K | +27.43% |
| 2016-12-31 | $16.41K | -6.83% |
| 2015-12-31 | $17.61K | -11.55% |
| 2014-12-31 | $19.91K | -10.15% |
| 2013-12-31 | $22.16K | +22061.00% |
| 2012-12-31 | $100.00 | -100.00% |
| 2008-12-31 | $3.09 Million | 0.00% |
| 2007-12-31 | $3.09 Million | -38.93% |
| 2006-12-31 | $5.06 Million | +255.86% |
| 2005-12-31 | $1.42 Million | +14.21% |
| 2004-12-31 | $1.25 Million | +50.64% |
| 2003-12-31 | $826.60K | -50.53% |
| 2002-12-31 | $1.67 Million | -- |